國立虎尾科技大學 |

The Basics of Cancer Immunotherapy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	The Basics of Cancer Immunotherapy/ edited by Haidong Dong, Svetomir N. Markovic.
other author:	Dong, Haidong.
Description:	X, 160 p. 8 illus., 4 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Medicine . -
Online resource:	https://doi.org/10.1007/978-3-319-70622-1
ISBN:	9783319706221

The Basics of Cancer Immunotherapy
The Basics of Cancer Immunotherapy[electronic resource] /edited by Haidong Dong, Svetomir N. Markovic. - 1st ed. 2018. - X, 160 p. 8 illus., 4 illus. in color.online resource.

The Basic Concepts in Cancer Immunology and Immunotherapy -- Therapeutic Targets of FDA-approved Immunotherapies in Oncology -- Melanoma Immunotherapy -- Significance of Immune Checkpoints in Lung Cancer -- Immunotherapy for Genitourinary Cancers -- Next-generation Immunotherapy in Lymphoma Immunotherapy -- Combined Immunothepary with Conventional Cancer Treatment -- Immunotherapy for Other Malignancies -- Management of Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy -- Resources for Patients.

This book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications of therapy. The patient-friendly, concise, easy-to-understand, and up-to-date knowledge presented in this book will inform patients about the benefits and risks of cancer immunotherapy, and help them and their care providers to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear and useful information to help them communicate with patients or address unresolved problems. Some key features of the book are: Expertise. All editors and authors are scientists and oncologists specializing in cancer immunotherapy, and are involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today’s daily patient care. Their insights, expertise and experience guarantee the high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written for cancer patients in order to meet their needs when considering immunotherapy. As an educational tool, this book will help the reader balance the risks and benefits based on both science and clinical facts, and therefore to make the best choice in receiving or withdrawing from immunotherapy. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease.

ISBN: 9783319706221

Standard No.: 10.1007/978-3-319-70622-1doiSubjects--Topical Terms:

1254474
Medicine .

LC Class. No.: R-RZ

Dewey Class. No.: 610

The Basics of Cancer Immunotherapy
LDR:04010nam a22003855i 4500 001 992435
003 DE-He213
005 20200703173903.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319706221 $9 978-3-319-70622-1
024 7 $a 10.1007/978-3-319-70622-1 $2 doi
035 $a 978-3-319-70622-1
050 4 $a R-RZ
072 7 $a VFD $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a VFD $2 thema
082 0 4 $a 610 $2 23
245 1 4 $a The Basics of Cancer Immunotherapy $h [electronic resource] / $c edited by Haidong Dong, Svetomir N. Markovic.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a X, 160 p. 8 illus., 4 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a The Basic Concepts in Cancer Immunology and Immunotherapy -- Therapeutic Targets of FDA-approved Immunotherapies in Oncology -- Melanoma Immunotherapy -- Significance of Immune Checkpoints in Lung Cancer -- Immunotherapy for Genitourinary Cancers -- Next-generation Immunotherapy in Lymphoma Immunotherapy -- Combined Immunothepary with Conventional Cancer Treatment -- Immunotherapy for Other Malignancies -- Management of Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy -- Resources for Patients.
520 $a This book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications of therapy. The patient-friendly, concise, easy-to-understand, and up-to-date knowledge presented in this book will inform patients about the benefits and risks of cancer immunotherapy, and help them and their care providers to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear and useful information to help them communicate with patients or address unresolved problems. Some key features of the book are: Expertise. All editors and authors are scientists and oncologists specializing in cancer immunotherapy, and are involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today’s daily patient care. Their insights, expertise and experience guarantee the high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written for cancer patients in order to meet their needs when considering immunotherapy. As an educational tool, this book will help the reader balance the risks and benefits based on both science and clinical facts, and therefore to make the best choice in receiving or withdrawing from immunotherapy. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease.
650 0 $a Medicine . $3 1254474
650 0 $a Health. $3 565198
650 0 $a Immunology. $3 592892
650 0 $a Cancer research. $3 1253664
650 1 4 $a Popular Science in Medicine and Health. $3 680150
650 2 4 $a Cancer Research. $3 668358
700 1 $a Dong, Haidong. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1284149
700 1 $a Markovic, Svetomir N. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1284150
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319706214
776 0 8 $i Printed edition: $z 9783319706238
856 4 0 $u https://doi.org/10.1007/978-3-319-70622-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)